StockVS

United-Guardian, Inc. (UG) स्टॉक विश्लेषण

रक्षात्मक उपभोक्ता

United-Guardian, Inc.

$7.10

$-0.07 (-0.98%)

अंतिम अपडेट: 26 मई 2026

प्राइस हिस्ट्री

विश्लेषण

कंपनी का अवलोकन

United-Guardian, Inc. (UG) operates as a specialized entity within the consumer defensive sector, specifically focusing on the household and personal products industry. The firm is dedicated to the development, manufacturing, and marketing of specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients for both domestic and international markets. As of the latest reporting period, the company maintains a market capitalization of $30.37M and reports trailing twelve-month revenue of $10.55M, though specific employee count data is not publicly disclosed in the current dataset. These valuation and revenue figures position United-Guardian as a smaller-cap enterprise relative to large conglomerates, indicating a niche market presence with a focus on specific ingredient formulations like LUBRAJEL.

वित्तीय स्वास्थ्य

The company generated $10.55M in revenue and recorded a net income of $2.11M over the trailing twelve months, resulting in an EBITDA of $2.35M. The gap between the $10.55M revenue and the $2.11M net income highlights a significant cost structure where approximately 80% of revenue is consumed by operating expenses, taxes, and interest before reaching the bottom line. Despite the revenue costs, the firm generated free cash flow of $845,767, which provides essential financial flexibility for capital expenditures or debt servicing without immediate external financing. United-Guardian holds a cash balance of $8.57M while carrying zero debt, creating a distinct contrast in its liquidity management strategy. The balance sheet exhibits a highly conservative stance given the absence of debt and a robust cash position relative to obligations. Profitability metrics further illustrate this conservative approach with a gross margin of 48.8%, an operating margin of 24.4%, and a profit margin of 20.0%. The current ratio stands at 7.31, signaling exceptional short-term liquidity and the ability to meet current liabilities with ease. Return on equity is recorded at 18.2% while return on assets is 10.4%, suggesting that management is utilizing shareholder equity efficiently to generate returns despite the asset-heavy nature implied by the ROA figure.

मूल्यांकन आकलन

The trailing twelve-month P/E ratio is 14.37, whereas the forward P/E ratio is not available, which limits the ability to assess expected earnings trajectory based on forward multiples. The price-to-book ratio is 2.70, indicating that the market values the company at a premium of 170% over its net asset book value. Alternative valuation metrics such as the price-to-sales ratio of 2.88 and an EV/EBITDA of 9.27 provide context for the company's valuation relative to its sales volume and earnings power. The stock has traded between a 52-week high of $9.88 and a 52-week low of $5.58, providing a clear range of historical volatility for price analysis. The beta value of 0.96 indicates that the stock's price volatility mirrors the broader market movements, suggesting it does not significantly amplify or dampen systemic risk.

Growth & Income

United-Guardian demonstrated revenue growth of 19.6% year-over-year and earnings growth of 29.0% year-over-year, revealing that earnings are expanding at a pace faster than revenue. This divergence implies improved operational efficiency or margin expansion driving profitability more aggressively than top-line sales volume. The company offers a dividend yield of 7.6%, which is substantial for a company of this size, though the payout ratio of 130.4% indicates that the dividend exceeds current earnings. Such a high payout ratio suggests the company may be relying on cash reserves or non-operating income to fund dividends, which warrants scrutiny regarding long-term sustainability given the zero debt and limited cash flow generation. The overall growth and income profile presents a mixed picture of strong top-line expansion and high earnings growth supported by a current dividend yield that exceeds the rate of earnings generation.

समकक्ष तुलना

United-Guardian, Inc. (UG) घरेलू और व्यक्तिगत उत्पाद उद्योग में कार्यरत है। बाजार पूंजीकरण के आधार पर इसके निकटतम समकक्षों से तुलना इस प्रकार है:

कंपनी टिकर मार्केट कैप P/E अनुपात
United-Guardian, Inc. UG $32.62M 13.7
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Colgate-Palmolive Company CL $71.90B 34.8

घरेलू और व्यक्तिगत उत्पाद उद्योग का औसत P/E अनुपात 29.9x है। United-Guardian, Inc. का P/E अनुपात 13.7 है।

यह विश्लेषण AI द्वारा केवल सूचनात्मक उद्देश्यों के लिए तैयार किया गया है और यह वित्तीय सलाह नहीं है। डेटा में देरी या अशुद्धि हो सकती है। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और किसी योग्य वित्तीय सलाहकार से परामर्श लें।

United-Guardian, Inc. के बारे में

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

कंपनी विवरण अंग्रेजी में दिखाया गया है।

वेबसाइट देखें →

मुख्य आंकड़े

मार्केट कैप
$32.62M
P/E अनुपात
13.65
52 सप्ताह उच्च
$9.88
52 सप्ताह निम्न
$5.58
औसत वॉल्यूम
4.49K
डिविडेंड यील्ड
7.04%

डेटा yfinance के माध्यम से Yahoo Finance द्वारा प्रदान किया गया है। दैनिक अपडेट।

कंपनी जानकारी

एक्सचेंज
NASDAQ
देश
United States
कर्मचारी
23